13.83
전일 마감가:
$13.48
열려 있는:
$13.53
하루 거래량:
62,914
Relative Volume:
0.97
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+12.26%
1개월 성능:
+19.22%
6개월 성능:
+16.81%
1년 성능:
+161.44%
Direxion Daily Pharmaceutical Medical Bull 3 X Etf Stock (PILL) Company Profile
명칭
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
전화
-
주소
-
Compare PILL vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
PILL
Direxion Daily Pharmaceutical Medical Bull 3 X Etf
|
13.83 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
365.76 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
740.96 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
742.61 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
293.07 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
722.51 | 124.43B | 0 | 0 | 0 | 0.00 |
Direxion Daily Pharmaceutical Medical Bull 3 X Etf 주식(PILL)의 최신 뉴스
Generalized Anxiety Disorder Market: Growth Momentum Across 7MM to 2036 – DelveInsight | VistaGen Therapeutics, Fabre-Kramer Pharm, Mind Med, Sunovion, ChemRar Research, Biohaven Pharma, Forest Lab - Barchart.com
Houston vs Los Angeles A: Total Runs - Coinbase
Dr. Eric Haeger Launches National Scholarship to Support the Next Generation of Medical Professionals - Barchart.com
Alpha Thalassemia Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Forma Therapeutics, Genmedicn Biopharma, Bristol-Myers Squibb, Agios Pharma - Barchart.com
(PILL) Risk Channels and Responsive Allocation - Stock Traders Daily
Osteoarthritis Market Gains Momentum with Expanding Pipeline and Investment Potential by 2036 – DelveInsight | Merck KGaA, Peptinov, LG Chem, Akan Bioscience, BioTissue,Inc., Eupraxia Pharma - Barchart.com
5 Biggest Biotechnology ETFs in 2026 - Investing News Network
SOXL: How Disciplined Tactical Moves In And Out Could Compound Wealth Over 30 Years - Seeking Alpha
Excessive Daytime Sleepiness Market Emerging as a High-Growth Healthcare Investment Space Through 2036 – DelveInsight | Avadel Pharma, Axsome Therapeutics, Theranexus, Suven LifeSciences, NLS Pharma - Barchart.com
How Is Union Pacific’s Stock Performance Compared to Other Transportation Stocks? - Barchart.com
CPKC to maintain rail operations across Canada during IBEW strike - Barchart.com
These 3 Software Stocks Are Buying Back Shares Hand Over Fist - Barchart.com
Trump ponders whether to move forward with Iran deal but hasn't yet decided - Barchart.com
Why Are Atlassian (TEAM) Shares Soaring Today - Barchart.com
CrowdStrike and Palo Alto Networks Shares Are Soaring, What You Need To Know - Barchart.com
PagerDuty (PD) Stock Trades Up, Here Is Why - Barchart.com
HVAC in Data Center Market to Reach USD 31.80 Billion by 2032 Driven by AI Workloads and Hyperscale Data Center Expansion - Barchart.com
Fears of a Poor India Monsoon Lift Sugar Prices - Barchart.com
The 180-Day Lease Holding Up SpaceX's $2 Trillion IPO - Barchart.com
A $6 Billion Reason Snowflake Stock Is Up Today - Barchart.com
VERI UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Veritone (VERI) Investors of Securities Class Action Deadline on July 20, 2026 - Barchart.com
How Is Adobe's Stock Performance Compared to Other Tech-Software Stocks? - Barchart.com
Marvell’s Q1 Earnings Strengthen Its Bull Case — But MRVL Stock Isn’t a Screaming Buy Yet - Barchart.com
Eshbal Announces Appointment of Nir Peles to Board of Directors, Achievement of Revenue Milestones and Ontario Continuance - Barchart.com
Hog Traders Looking to Friday Trade - Barchart.com
Indonesians mark 20 years since mud volcano eruption swallowed up entire communities in East Java - Barchart
2 Services Stocks with Impressive Fundamentals and 1 We Avoid - Barchart.com
3 Reasons IP is Risky and 1 Stock to Buy Instead - Barchart.com
France’s parliament votes to repeal slavery-era Black Code, with tears and history in the chamber - Barchart.com
Caesars Entertainment, a Las Vegas Strip icon, is sold for nearly $6 billion - Barchart.com
Sportradar Securities Fraud Class Action Result of Compliance Misrepresentations and 22% Stock DeclineInvestors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC - Barchart.com
Apex Trader Funding Launches Massive 90% Off Promotion, New 5-Pack Bundles, and Zero Activation Fee Options for Futures Traders - Barchart.com
Zelenskyy says he's pressing US for more Patriot missiles for Ukraine to counter Russian strikes - Barchart.com
Hola Prime’s Independent Deloitte Review Validates Zero Payout Denials - Barchart.com
Dollar General (DG) Shares Skyrocket, What You Need To Know - Barchart.com
One Tech Tip: Your next job interview could be with an AI bot - Barchart.com
Unusual Options Activity in Key ETFs Unveils 3 Trade Ideas Here - Barchart.com
Brazil is set to join other Latin American countries with a 40-hour, 5-day workweek - Barchart.com
Shareholder Alert: Ademi LLP investigates whether Caesars Entertainment, Inc. is obtaining a Fair Price for Public Shareholders - Barchart.com
Global X Investments Canada ouvre les marchés - Barchart.com
The $3 Trillion Battery Problem’s Bigger Than You Think. But Not For This Startup. - Barchart.com
April Core PCE Grows 3.3%, Highest Rate in 30 Months - Barchart.com
Arbe Robotics Q1 Earnings Call Highlights - Barchart.com
Corn Bouncing on Thursday AM Trade - Barchart.com
US jobless claims rose to 215,000 last week, but layoffs remain low despite economic uncertainty from the Iran war - Barchart.com
Micron Stock Just Added 3X More Value in One Day Than the Entire Company Was Worth Last Year - Barchart.com
Gamification and memes lure young people to sports wagering apps, prediction markets - Barchart.com
Seamless Commute-to-Weekend Style: Zeagoo x Maye Musk’s Summer Wardrobe Picks - Barchart.com
SRAD Investors Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit with the Schall Law Firm - Barchart.com
In a tourist-friendly move, China's Tencent to allow PayPal payments through its WeChat networks - Barchart
3 Reasons to Sell DGX and 1 Stock to Buy Instead - Barchart.com
Direxion Daily Pharmaceutical Medical Bull 3 X Etf (PILL) 재무 분석
Direxion Daily Pharmaceutical Medical Bull 3 X Etf (PILL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):